MSH|^~\&|MIC|SMH|||202002101425||ORU^R01|4165030|D|2.3|||AL|NE
PID|1||SM00047089|SM46869|MICTEST^HOPEFUL^||20191201|F||||||||||SM003710/19|9874801766
OBR|1|39140^MIC|00029510^20:W0000021M^MIC^20:W21^39140|310.1010^WND^Wound (Deep) culture \T\ gram^^^43407-6||202002101129|202002101128|||||||202002101424|Abscess (deep)^^^Ankle|||||||||MB|I||||
OBX|1|ST|100.0110^GSW^Gram stain^^664-3^664-3^P:GRAM|1|||||||F|||202002101425
OBX|2|ST|100.0110^GSW^Gram stain^^664-3^664-3^R:3 P|1|3+ Polymorphonuclear cells||||||F|||202002101425
OBX|3|ST|100.0110^GSW^Gram stain^^664-3^664-3^R:2 GNB|1|2+ Gram negative bacilli||||||F|||202002101425

MSH|^~\&|LAB|ARH|||202002101426||ORU^R01|4165033|D|2.3|||AL|NE
PID|1||AB00006618|AB6617|LABTEST^CACTUS^||19621109|F||||||||||AB000407/18|9875909325
OBR|1|39170^LAB|00029538^1002:C00020R^LAB^100220:C20^39170|499.0048^QCOWCARM1^QC ONE WORLD CARDIAC MARKERS 1^^^||202002101425|202002101425|||||||202002101425||||||||||LAB|F||||
OBX|1|ST|500.5650^BNP R^B Type Natriuretic Peptide^^30934-4^30934-4|1|50^^Y|pg/mL|0-100|N||A^S|F|||202002101426
NTE|1||BNP Interpretive Guidelines:
NTE|2||< 100     pg/mL  Does not support CHF
NTE|3||100 - 250 pg/mL  Borderline zone CHF
NTE|4||250 - 400 pg/mL  Supports CHF
NTE|5||> 400     pg/mL  Strongly supports CHF
NTE|6||Contact designated speciality Pathologist if required.
OBX|2|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|5.0^^Y|mg/L|<7.5|N||A^S|F|||202002101426
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.

MSH|^~\&|MIC|SMH|||202002101426||ORU^R01|4165034|D|2.3|||AL|NE
PID|1||SM00047089|SM46869|MICTEST^HOPEFUL^||20191201|F||||||||||SM003710/19|9874801766
OBR|1|39140^MIC|00029510^20:W0000021M^MIC^20:W21^39140|310.1010^WND^Wound (Deep) culture \T\ gram^^^43407-6||202002101129|202002101128|||||||202002101424|Abscess (deep)^^^Ankle|||||||||MB|F||||
OBX|1|ST|100.0110^GSW^Gram stain^^664-3^664-3^P:GRAM|1|||||||F|||202002101425
OBX|2|ST|100.0110^GSW^Gram stain^^664-3^664-3^R:3 P|1|3+ Polymorphonuclear cells||||||F|||202002101425
OBX|3|ST|100.0110^GSW^Gram stain^^664-3^664-3^R:2 GNB|1|2+ Gram negative bacilli||||||F|||202002101425
OBX|4|CE|310.2010^WNDC^Wound culture (Deep)^^6463-4^43407-6^O:ECOL|2.1|ECOL^Escherichia coli||||||F|||202002101426
OBX|5|ST|310.2010^WNDC^Wound culture (Deep)^^6463-4^43407-6^P:AMT|2.1|||||||F|||202002101426
OBX|6|ST|310.2010^WNDC^Wound culture (Deep)^^6463-4^43407-6^R:2|2.1|2+||||||F|||202002101426
OBR|2||00029510^20:W0000021M^MIC^20:W21^39140|903.3100^N213^Vitek N213 Sensitivity^^^29576-6||202002101129|202002101128|||||||202002101424|Abscess (deep)^^^Ankle|||||||||MB|F|6463-4^2.1|||39140^MIC
OBX|1|ST|100.400^CFT^Cefotaxime^^108-1^108-1|||||S|||F|||202002101426
OBX|2|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||S|||F|||202002101426
OBX|3|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||202002101426
OBX|4|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||202002101426
OBX|5|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||S|||F|||202002101426
OBX|6|ST|200.100^AM^Ampicillin^^28-1^28-1|||||S|||F|||202002101426
OBX|7|ST|200.400^PT^Piperacillin/Tazobactam^^412-7^412-7|||||S|||F|||202002101426
OBX|8|ST|300.200^GM^Gentamicin^^267-5^267-5|||||S|||F|||202002101426
OBX|9|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||202002101426